ARZU ATASEVEN, Gulcan Saylam KURTİPEK, Perihan ÖZTÜRK

Neutrophil Lymphocyte Ratio in Patients Receiving Isotretinoin for Acne Vulgaris

The aim of this study is to assess the neutrophil, lymphocyte and neutrophil lymphocyte ratio in patients receiving isotretinoin for acne treatment. 110 (64 women, 46 men) patients with acnevulgaris were included in this study. Patients were treated with 0.5-1 mg/kg/day isotretinoin. The laboratory results were collected retrospectively from the patients' records. Neutrophils, lymphocytes, and neutrophils lymphocytes ratio before treatment and at the third months after the treatment were collected retrospectively. Statistical analysis was performed using PASW Statistics 18. Paired sample T-test was used to compare pre-and post treatment parameters. The mean number of neutrophils in patients with pre-treatment and post-treatment were; 4354±1623 and 4147±1659, the mean lymphocyte counts were 2410±716 and 2384±681 and NLO values before and after treatment were 2.06 ±1.42 and 2.00 ±1.99, respectively. There is no statistically significant difference for the three values (p> 0.05). The effect of isotretinoin therapy in patients with acne vulgaris is not determined on neutrophil and lymphocyte counts and neutrophil lymphocyte ratio.

PDF

___

1. Brito Mde F, Sant'Anna IP, Galindo JC, Rosendo LH, Santos JB. Evaluation of clinical adverse effects and laboratory alterations in patients with acne vulgaris treated with oral isotretinoin. An Bras Dermatol. 2010;85(3) 331-7.

2. Polat M, Oztaş P, Ilhan MN, Allı N. Clinical side effects and results of systemic isotretinoin treatment in patient with nodulocystic acne. Turkiye Klinikleri J Dermatol. 2008;18(2):72-6.

3. Vieira AS, Beijamini V, Melchiors AC. The effect of isotretinoin on triglycerides and liver aminotransferases. An Bras Dermatol 2012;87(3):382-7.

4. Ertaş G, Sönmez O, Turfan M, Kul S, Erdoğan E, Tasal A et al. Neutrophil/lymphocyte ratio is associated with thromboembolic stroke in patients with non-valvular atrial fibrillation. J Neurol Sci. 2013; 324(1-2):49-52.

5. Kao SC, Pavlakis N, Harvie R, Vardy JL, Boyer MJ, van Zandwijk N, Clarke SJ. High blood neutrophil- to- lymphocyte ratio is an indicator of poor prognosis in malignant mesothelioma patients undergoing systemic therapy. Clin Cancer Res. 2010;16:(23):5805-13.

6. Park JJ, Jang HJ, Oh IY, Yoon CH, Suh JW, Cho YS, Youn TJ, Cho GY, Chae IH, Choi DJ. Prognostic value of neutrophil lymphocyte ratio in patients presenting with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention. Am J Cardiol. 2013;111(5):636-42.

7. Jansen T, Altmeyer P. Thrombocytosis induced by low-dose isotretinoin. Int J Dermatol. 2000;39:956-7. 8. Moeller KE, Touma SC. Prolonged thrombocytopenia associated with isotretinoin. Ann Pharmacother. 2003;37(11):1622-4.

9. Hesdorffer CS, Weltman MD, Raftopoulos H, Mendelow B, Bezwoda WR. Thrombocytopenia induced by isotretinoin. S Afr Med J. 1986;70:705-6.

10. Aurousseau MH, Levacher S, Beneton C, et al. Dysfibrinogenemie et thrombocytopenie transitoires associees a une pancreatite aigue recidivante lors d'un traitement par l'isotretinoine. Rev Med Interne. 1995;16:622-5.

11. Camisa C, Eisenstat B, Ragaz A, Weissmann G. The effects of retinoids on neutrophil functions in vitro. J Am Acad Dermatol. 1982;6(4):620-9.

12. Pigatto PD, Fioroni A, Riva F, Brugo MA, Morandotti A, Altomare GF, Finzi AF. Effects of isotretinoin on the neutrophil chemotaxis in cystic acne. Dermatologica 1983;167(1):16-8.

13. Michaëlsson G, Vahlquist A, Mobacken H, Hersle K, Landegren J, Rönnerfält L, Nordin K, Franzén K, Pettersson U. Changes in laboratory variables induced by isotretinoin treatment of acne. Acta Derm Venereol. 1986;66(2):144-8.

14. Imtiaz F, Shafique K, Mirza SS, Ayoob Z, Vart P, Rao S. Neutrophil lymphocyte ratio as a measure of systemic inflammation in prevalent chronic diseases in Asian population. Int Arch Med. 2012;26:5(1):2.

15. Wang GY, Yang Y, Li H, Zhang J, Jiang N, Li MR, Zhu HB, Zhang Q, Chen GH. A scoring model based on neutrophil to lymphocyte ratio predicts recurrence of HBVassociated hepatocellularcarcinoma after liver transplantation. PLoS One. 2011;6(9):e25295.

16. Oh BS, Jang JW, Kwon JH, You CR, Chung KW, Kay CS, Jung HS, Lee S. Prognostic value of C-reactive protein and neutrophil-to-lymphocyte ratio in patients with hepatocellular carcinoma. BMC Cancer. 2013;13(1):78.

17. Ohno Y, Nakashima J, Ohori M, Tanaka A, Hashimoto T, Gondo T, Hatano T, Tachibana M. Clinical variables for predicting metastatic renal cell carcinoma patients who might not benefit from cytoreductive nephrectomy: neutrophil-to-lymphocyte ratio and performance status. Int J Clin Oncol. 2013. [Epub ahead of print].

18. Tasoglu I, Sert D, Colak N, Uzun A, Songur M, Ecevit A. Neutrophil-to-lymphocyte ratio predict the limb survival in critical limb ischemia. Clin Appl Thromb Hemost. 2013.[Epub ahead of print].

19. Kaya A, Kurt M, Tanboga IH, Isik T, Günaydin ZY, Kaya Y, Topcu S, Sevimli S.Relation of neutrophil-to-lymphocyte ratio with the presence and severity of stable coronary artery disease. Clin Appl Thromb Hemost 2013. .[Epub ahead of print].